International Journal of Antimicrobial Agents

Article	Citations
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page	122
Title Page & Editorial Board	109
Daptomycin non-susceptible Staphylococcus argenteus isolated from a patient without prior antibiotic exposure	101
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page	84
Cystathionine γ-lyase: The Achilles heel of bacterial defense systems	82
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page	73
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page	71
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page	65
Enhanced targeted NGS assay for comprehensive diagnosis in tuberculosis and drug-resistant tuberculosis patients	64
LightCPPgen: An explainable machine learning pipeline for rational design of cell penetrating peptides	62
Erratum to “Empiric antibiotic protocols for cancer patients with neutropenia: a single–center study of treatment efficacy and mortality in patients with bacteremia” [International Journal of Antimicr	61
Impact of a newly established expert clinical pharmacological advice programme based on therapeutic drug monitoring results in tailoring antimicrobial therapy hospital-wide in a tertiary university ho	56
Large-scale comparative analysis reveals phylogenomic preference of blaNDM-1 and blaKPC-2 transmission among Klebsiella pneumoniae	52
Global prevalence of fosfomycin resistance genes fosA and fosB in multidrug-resistant bacteria	49
Efficacy of clofazimine-containing regimens for treatment of Mycobacterium avium complex–pulmonary disease in patients unsuitable for standard treatment regimen	49
Antifungal activity and potential mechanism of action of caspofungin in combination with ribavirin against Candida albicans	48
Beyond parasite clearance: Three unresolved methodological challenges in cross-regional PKDL trials	46
A contribution on the fosfomycin mechanism of resistance in multidrug-resistant organisms	45
Dysbiosis of the gut microbiota is associated with in-hospital mortality in patients with antibiotic-associated diarrhoea: A metagenomic analysis	43
Development of a new antibiotic-induced dysbiosis model of the canine colonic microbiota	42
Synergistic effects of inhaled aztreonam plus tobramycin on hypermutable cystic fibrosis Pseudomonas aeruginosa isolates in a dynamic biofilm model evaluated by mechanism-based modelling and whole gen	42
Title Page & Editorial Board	41
Characterisation of the genome of a Klebsiella pneumoniae clinical strain carrying a novel KPC-205 variant associated with resistance to ceftazidime/avibactam and cefiderocol	41
Machine–learning and gene–synergy networks reveal interpretable drivers of antibiotic resistance in Staphylococcus aureus	40
Immunomodulator AS101 restores colistin susceptibility of clinical colistin-resistant Escherichia coli and Klebsiella pneumoniae in vitro and in vivo	40

Daily fluid intake as a novel covariate affecting the population pharmacokinetics of polymyxin B in patients with sepsis	39
Molecular mechanisms and clonal distribution of cefiderocol-resistant blaNDM-carrying Escherichia coli: A multi-centre study in China	39
Effectiveness of rifampicin combination therapy for orthopaedic implant-related infections: A systematic review and meta-analysis	38
The New Delhi metallo-β-lactamase-1 biosensor rapidly and accurately detected antibiotic plasma concentrations in cefuroxime-treated patients	37
Outcomes of Daptomycin Plus Ceftaroline Versus Alternative Therapy for Persistent Methicillin-resistant Staphylococcus aureus (MRSA) Bacteraemia	37
Antibiotic spectrum index as an antimicrobial stewardship tool in paediatric intensive care settings	37
In reply to the Letter to the Editor regarding Intrathecal or intraventricular antimicrobial therapy for post-neurosurgical Gram-negative bacillary meningitis or ventriculitis: A systematic review and	36
Lopinavir and ritonavir act synergistically with azoles against Candida auris in vitro and in a mouse model of disseminated candidiasis	36
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page	36
Antibiotic resistance in Enterobacter hormaechei	36
Characterization of the extended substrate spectrum of the class A β-lactamase CESS-1 from Stenotrophomonas sp. and structure-based investigation into its substrate preference	34
Proguanil and chlorhexidine augment the antibacterial activities of clarithromycin and rifampicin against Acinetobacter baumannii	34
Individualised amoxicillin-clavulanate dosing recommendations for critically ill children with augmented clearance after cardiac surgery	34
Safety and efficacy of a phage cocktail on murine wound infections caused by carbapenem-resistant Klebsiella pneumoniae	33
Machine learning accelerates the discovery of epitope-based dual-bioactive peptides against skin infections	33
Zanamivir and baloxavir combination to cure persistent influenza and coronavirus infections after hematopoietic stem cell transplant	33
Validation of limited sampling strategies for polymyxin B therapeutic drug monitoring in critical care	32
Detection of mcr-1-harbouring Escherichia coli by quantum dot labelling of synthetic small peptides mimicking lipopolysaccharide receptors	32
An easy-to-use predictive score for identifying patients at risk of suboptimal linezolid exposure and candidates for therapeutic drug monitoring	32
Efficacy of combination therapy with standard-dose carbapenem for treating nosocomial pneumonia caused by carbapenem-resistant Acinetobacter baumannii in intensive care units: A multicentre retrospect	32
Cross-talk between signal transduction systems and metabolic networks in antibiotic resistance and tolerance	31
Effectiveness of mRNA BNT162b2 and inactivated CoronaVac vaccines against severe COVID-19 outcomes among non-hospitalised children aged 1-3 years with SARS-CoV-2 Omicron infection	31
Global, regional, and national burden of multidrug-resistant organisms, 1990–2021	31
Silent dissemination of fosfomycin resistance genes in critical-priority Klebsiella pneumoniae	31
Emergence of TMexCD-TOprJ-producing Vibrio furnissii in retail shellfish	31
In vitro susceptibilities of isolates of potentially naturally inducible chromosomal AmpC-producing metallo-β-lactamase-negative carbapenem-resistant Enterobacterales species to ceftazidime-avibactam:	31
Intravenous Fosfomycin as Adjunctive Therapy for Gram-Negative Bacteria Bloodstream Infections: A Propensity Score Adjusted Retrospective Cohort Study	30
Rapid detection of NDM-producing carbapenem-resistant Escherichia coli using MALDI-TOF MS combined with machine learning techniques	30
Impact of pre‐existent drug resistance on virological efficacy of single‐tablet regimens in people living with HIV	30
Adverse effects of posaconazole on adrenal steroid biosynthesis: An integrative approach using FAERS-based pharmacovigilance and systematic review with meta-analysis of randomised controlled trials	30
Reply to the letter to the editor regarding ‘Acute kidney injury associated with colistin sulfate vs. polymyxin B sulfate therapy: A real-world, retrospective cohort study’	29
Comment on “Beneficial effects of a compound probiotic in Helicobacter pylori-infected patients aged over 40 years: An open-label randomized clinical trial”	29
A Systematic Review of the Pharmacokinetics and Pharmacodynamics of Novel Beta-Lactams and Beta-Lactam with Beta-Lactamase Inhibitor Combinations for the Treatment of Pneumonia Caused by Carbapenem-Re	29
Effectiveness of third-generation cephalosporins or piperacillin compared with cefepime or carbapenems for severe infections caused by wild-type AmpC β-lactamase-producing Enterobacterales: A multi-ce	29
The ATP-binding cassette transporter CstA as a novel therapeutic target for treating carbapenem-resistant Enterobacteriaceae bacteria	28
Targeting the human protein disulfide isomerase A3 as a broad-spectrum antiviral approach against human respiratory viruses	28
Activity of aztreonam/avibactam and ceftazidime/avibactam against Enterobacterales with carbapenemase-independent carbapenem resistance	28
Aerosolized plus intravenous polymyxin B in comparison to intravenous polymyxin B alone for the management of HAP caused by carbapenem-resistant gram-negative bacteria: A prospective multicenter cohor	28
Resistance of Gram-negative bacteria to aztreonam-avibactam: An evaluation of data from in vitro studies	27
Pretomanid resistance: An update on emergence, mechanisms and relevance for clinical practice	27
Metagenomic next-generation sequencing on treatment strategies and prognosis of patients with lower respiratory tract infections: A systematic review and meta-analysis	27
Treatment of infections caused by multidrug-resistant Gram-negative bacilli: A practical approach by the Italian (SIMIT) and French (SPILF) Societies of Infectious Diseases	27
EN-DALBACEN 2.0 Cohort: real-life study of dalbavancin as sequential/consolidation therapy in patients with infective endocarditis due to Gram-positive cocci	27
Flavonols interrupt internalized bacteria hijacking cellular responses via suppressing oxidative stress induced cellular apoptotic death	27
Clinical and laboratory insights into the threat of hypervirulent Klebsiella pneumoniae	26
Global evolutionary dynamics of virulence genes in ST11-KL47 carbapenem-resistant Klebsiella pneumoniae	26
Population pharmacokinetics of levornidazole in healthy subjects and patients, and sequential dosing regimen proposal using pharmacokinetic/pharmacodynamic analysis	26
Mechanisms and fitness of ceftazidime/avibactam-resistant Klebsiella pneumoniae clinical strains in Taiwan	25
Urinary exosome-derived microRNAs as biomarkers of tenofovir disoproxil fumarate (TDF)-induced renal toxicity in people with HIV-1	25
Impact of cefiderocol on Klebsiella pneumoniae: A population-based longitudinal analysis of phenotypic and genotypic responses at subinhibitory and inhibitory concentrations	25

Plasma, intracellular and lymph node antiretroviral concentrations and HIV DNA change during primary HIV infection: Results from the INACTION P25 study	24
Pharmacokinetics/pharmacodynamics of cefiderocol administered by continuous infusion in a case series of critically ill patients with carbapenem-resistant Acinetobacter baumannii infections undergoing	24
Isavuconazole dosing in Asian patients with invasive mould infections: is there a role for therapeutic drug monitoring?	24
Early risk stratification in Staphylococcus aureus bacteraemia: External validation of the FEN-AUREUS classification in a UK cohort	24
Low-level viraemia and virologic failure among people living with HIV who received maintenance therapy with co-formulated bictegravir, emtricitabine and tenofovir alafenamide versus dolutegravir-based	24
New-generation antibiotics and nonantibiotic strategies against carbapenemase-producing Enterobacterales: More focus on metallo-β-lactamase producers	23
Title Page & Editorial Board	23
High concentrations of nirmatrelvir/ritonavir in critically ill patients receiving continuous renal replacement therapy	23
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page	23
Molecular investigation of an epidemic dissemination of vancomycin-resistant Enterococcus faecium sequence type 80 in Guangdong province, China	23
Large scale laboratory evolution uncovers clinically relevant collateral antibiotic sensitivity	22
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page	22
Title Page & Editorial Board	22
Staphylococcus aureus bacteraemia treatment outcomes in patients receiving ticagrelor vs a propensity-matched cohort receiving clopidogrel	22
Verapamil enhances the activity of Caspofungin against Cryptococcus neoformans， coinciding with inhibited Ca2+/CN pathway and damage to cell wall integrity	22
Corrigendum to “Clinical and Economic Evaluation of Blood Culture Whole Process Optimisation in Critically Ill Adult Patients With Positive Blood Cultures” [International Journal of Antimicrobial Agen	22
Beware of resistance to 2nd-generation integrase inhibitors: A systematic meta-analysis of HIV-1 integrase inhibitors resistance and drug resistance mutations	22
Toxoplasma gondii infection or acute retinal necrosis in early stage: A case report	22
Immunogenicity of the 13-valent pneumococcal conjugate vaccine followed by the 23-valent pneumococcal polysaccharide vaccine in people living with HIV on combination antiretroviral therapy	22
Antibiotic susceptibility of Gram-negative bacteria in cerebrospinal fluid compared with Mueller-Hinton broth and artificial cerebrospinal fluid	21
Title Page & Editorial Board	21
Novel active Trp- and Arg-rich antimicrobial peptides with high solubility and low red blood cell toxicity designed using machine learning tools	21
Global distribution of blaCMY-42, a gene mediating reduced susceptibility to aztreonam-avibactam and ceftazidime-avibactam, in Escherichia coli	21
Ceftazidime/avibactam-resistant carbapenem-resistant Klebsiella pneumoniae in China: A nationwide multicenter study	21
Plasma and subcutaneous interstitial fluid vancomycin and gentamicin concentrations in three patients undergoing open abdominal aortic aneurysm repair	21
Comparative efficacy of dalbavancin alone and with rifampicin against in vitro biofilms in a pharmacodynamic model with methicillin-resistant Staphylococcus aureus	21
Longitudinal fluctuations of common antimicrobial resistance genes in the gut microbiomes of healthy Dutch individuals	21
Clinical outcomes of rifampicin combination therapy in implant-associated infections due to staphylococci and streptococci: A systematic review and meta-analysis	21
Evaluation of synergistic activity of fosfomycin in combination with novel ß-lactams/ß-lactamase inhibitor combinations (βL-βLICs) against KPC-producing Klebsiella pneumoniae clinical isolates	20
A review of recently discovered mechanisms of cephalosporin resistance in Pseudomonas aeruginosa	20
In-vitro activity of oral third-generation cephalosporins plus clavulanate against ESBL-producing Enterobacterales isolates from the MERINO trial	20
Respiratory fluoroquinolone monotherapy for community-acquired pneumonia: a revised trial sequential analysis	20
Tracking emergence and outbreak of Klebsiella pneumoniae co-producing NDM-1 and KPC-2 after sulfamethoxazole-trimethoprim treatment: Insights from genetic analysis	20
Treatment sequences of a phage and colistin combination trigger different evolution pathways of a multidrug-resistant Acinetobacter baumannii yielding distinct treatment outcomes	20
Title Page & Editorial Board	20
Shifting trends in bloodstream infection-causing microorganisms and their clinical impact in patients with haematologic malignancies in South Korea: A propensity score-matched study	20
Analysis of time-to-positivity data in tuberculosis treatment studies: Identifying a new limit of quantification	20
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page	20
The current state of laboratory mycology in Asia/Pacific: A survey from the European Confederation of Medical Mycology (ECMM) and International Society for Human and Animal Mycology (ISHAM)	20
Pleural penetration of amoxicillin and metronidazole during pleural infection: An ambispective cohort study	20
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page	20
High-level delafloxacin resistance through the combination of two different mechanisms in Staphylococcus aureus	20
Renal function and its impact on the concentration of ceftazidime-avibactam: A cross-sectional study	19
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page	19
Genome-wide insight into the evolution and global transmission of tigecycline resistant tet(X4)-carrying Klebsiella species across reservoirs	19
BPI23-Fcγ alleviates lethal multi-drug-resistant Acinetobacter baumannii infection by enhancing bactericidal activity and orchestrating neutrophil function	19
Corrigendum to “Activity of cefiderocol and innovative β-lactam/β-lactamase inhibitor combinations against isogenic strains of Escherichia coli expressing single and double β-lactamases under high and	19
Pharmacodynamic insights to support pneumonia treatment in a patient co-infected with two carbapenem-resistant bacteria	19
Population pharmacokinetics and dosing regimen optimization of ceftazidime in plasma and cerebrospinal fluid of neonatal sepsis patients	18
Functional characterization and clinical implication of a novel epidemic carbapenem-resistant Acinetobacter baumannii genetic marker	18
Activity of aztreonam in combination with novel β-lactamase inhibitors against metallo-β-lactamase-producing Enterobacterales from Spain	18
High prevalence of clonally related ST182 NDM-1-producing Enterobacter cloacae complex clinical isolates in Greece	18
Risk of Clostridioides difficile infection following different antibiotics: insights from multi-source medical data	18
Emergence of ceftazidime-avibactam resistance in blaKPC-33-harbouring ST11 Klebsiella pneumoniae in a paediatric patient	18
Rising threat of metallo-β-lactamase-producing Klebsiella oxytoca complex in Taiwan, 2013–2022	18
High-throughput mutagenesis and screening approach for the identification of drug-resistant mutations in the rifampicin resistance-determining region of mycobacteria	18
Comparing novel antibiotics and carbapenems for complicated intra-abdominal infections: a systematic review and meta-analysis of randomized controlled trials	18
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page	18
Optimal dosing regimen of biapenem based on population pharmacokinetic/pharmacodynamic modelling and Monte Carlo simulation in patients with febrile neutropenia and haematological malignancies	18
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page	18
Comparative efficacy and safety of systemic antifungal agents for candidemia: a systematic review with network meta-analysis and multicriteria acceptability analyses	18
Clinical efficacy of ceftazidime/avibactam combination therapy for severe hospital-acquired pulmonary infections caused by carbapenem-resistant and difficult-to-treat Pseudomonas aeruginosa	18
Nafcillin Augmentation of Daptomycin and Cathelicidin LL-37 Killing of Methicillin-resistant Staphylococcus epidermidis: Foundations of Successful Therapy of Endocarditis	17
REDS study: Retrospective effectiveness study of dalbavancin and other standard of care of the same IV antibiotic class in patients with ABSSSI	17
Factors associated with meropenem pharmacokinetic/pharmacodynamic target attainment in septic critically ill patients treated with extended intermittent infusion or continuous infusion	17
Acute kidney injury associated with colistin sulfate vs. polymyxin B sulfate therapy: A real-world, retrospective cohort study	17
Efficacy and safety of intracameral amphotericin B for fungal keratitis: A systematic review and meta-analysis	17
Evaluation of tetracycline and fluoroquinolone therapy against Japanese spotted fever: Analysis based on individual data from case reports and case series	17
Letter to the Editor: Comment to ‘Assessment of Dientamoeba fragilis interhuman transmission by faecal microbiota transplantation’ by Moreno-Sabater et al. (2025)	16
Efficacy and safety of antiviral plus anti-spike monoclonal antibody combination therapy vs. monotherapy for high-risk immunocompromised patients with mild-to-moderate SARS-CoV2 infection during the O	16
cirA promoter disruption and SHV-12 production contribute to cefiderocol resistance in carbapenem-resistant Klebsiella pneumoniae	16
Ferric chloride induces ferroptosis in Pseudomonas aeruginosa and heals wound infection in a mouse model	16
Enhanced endotoxin release by select generic meropenem formulations in Pseudomonas aeruginosa	16
Susceptibility of Southeast Asian Plasmodium falciparum isolates to P218	16
Therapeutic drug monitoring-guided treatment versus standard dosing of voriconazole for invasive aspergillosis in haematological patients: a multicentre, prospective, cluster randomised, crossover cli	16
Comment on ‘Antibiotic class comparisons for the treatment of pyelonephritis and complicated urinary tract infections: A systematic review and meta-analysis’	16
Multicentre Clinical Evaluation of a Molecular Diagnostic Assay to Identify Neisseria gonorrhoeae Infection and Detect Antimicrobial Resistance	16
Clinical efficacy of cefiderocol-based regimens in patients with carbapenem-resistant Acinetobacter baumannii infections: New data from CREDIBLE-CR with an updated meta-analysis	16
Pharmacokinetic and preclinical safety studies of endolysin-based therapeutic for intravenous administration	16
Safety of high loading doses of teicoplanin: POSY-TEICO, a prospective, multicentre, observational study	16

Strategies for quorum sensing inhibition as a tool for controlling Pseudomonas aeruginosa infections	15
Cellular and genetic changes during and after fluconazole exposure in Cryptococcus neoformans	15
A novel indolylbenzoquinone compound HL-J6 suppresses biofilm formation and α-toxin secretion in methicillin-resistant Staphylococcus aureus	15
Access to phage therapy at Hospices Civils de Lyon in 2022: Implementation of the PHAGEinLYON Clinic programme	15
Stepwise within-host evolution of a blaCTX-M-27-positive Klebsiella pneumoniae clone under changing antimicrobial pressures leading to enhancement of β-lactam resistance	15
Persistence and dynamic structures of diverse cephalosporinase genes in nontyphoidal Salmonella in cross-sectional surveillance in Taiwan	15
The antimicrobial activity of innate host-directed therapies: A systematic review	15
In Vivo emergence of ceftazidime/avibactam, cefiderocol and aztreonam/avibactam cross-resistance in a patient with KPC-producing infection after cefiderocol-based treatment	15
In reply to comment on “Risk factors and serum concentration thresholds associated with tigecycline-induced hepatotoxicity in critically ill patients”	15
Sequential treatment effects on phage–antibiotic synergistic application against multi-drug-resistant Acinetobacter baumannii	15
Present trajectories to forecasted future: A longitudinal analysis of hospital antibiotic use in China from 2013 to 2024 and projections to 2030	15
Two natural compounds as potential inhibitors against the Helicobacter pylori and Acinetobacter baumannii IspD enzymes	15
Long-term effects of ciprofloxacin treatment on the gastrointestinal and oropharyngeal microbiome are more pronounced after longer antibiotic courses	15
FL058, a novel β-lactamase inhibitor, increases the anti-Mycobacterium abscessus activity of imipenem	15
Clinical effectiveness of molnupiravir in patients with COVID-19 undergoing haemodialysis	14
Title Page & Editorial Board	14
The emergence of transposon-driven multidrug resistance in invasive nontypeable Haemophilus influenzae over the last decade	14
Antimicrobial surveillance: A 20-year history of the SMART approach to addressing global antimicrobial resistance into the future	14
Anti-Porphyromonas gingivalis nanotherapy for maintaining bacterial homeostasis in periodontitis	14
Title Page & Editorial Board	14
Susceptibility of OXA-48-producing Enterobacterales to imipenem/relebactam, meropenem/vaborbactam and ceftazidime/avibactam	14
Ceftolozane/tazobactam plus tobramycin against free-floating and biofilm bacteria of hypermutable Pseudomonas aeruginosa epidemic strains: Resistance mechanisms and synergistic activity	14
Candida parapsilosis isolates carrying mutations outside FKS1 hotspot regions confer high echinocandin tolerance and facilitate the development of echinocandin resistance	14
Intravenous fosfomycin in combination regimens as a treatment option for difficult-to-treat infections due to multi-drug-resistant Gram-negative organisms: A real-life experience	14
In vitro activities of ceftazidime–avibactam, ceftolozane–tazobactam, meropenem–vaborbactam and other comparators against Pseudomonas aeruginosa isolates with discrepant resistance to carbapenems: Dat	14
Title Page & Editorial Board	14
Extraintestinal pathogenic Escherichia coli (ExPEC) O-serotype distribution and antibiotic resistance profiles among the aging population in China: A longitudinal, multi-center study	14
A 22-year Brazilian colistin resistance surveillance on Escherichia coli and Salmonella spp. originating from food-producing animals	14
Efficacy of ceftazidime-avibactam in various combinations for the treatment of experimental osteomyelitis due to Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae	14
Models for cytotoxicity screening of antileishmanial drugs: what has been done so far?	14
Molecular typification of Escherichia coli from community-acquired urinary tract infections in Mexico	14
Artemisinin-piperaquine versus artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Grande Comore island: an open-label, non-randomised controlled trial	14
Development of multiplex recombinase polymerase amplification for the rapid detection of five carbapenemase (blaKPC, blaNDM, blaOXA-48-like, blaIMP, and blaVIM) and 10 mcr (mcr-1 to mcr-10) genes in b	14
Model-informed precision pyrazinamide dosing: The establishment of a population pharmacokinetic model repository for clinical decision support	14
Trial Sequential Analysis of Intrathecal/Intraventricular Antimicrobial Therapy for Post-Neurosurgical Gram-Negative Bacillary Meningitis or Ventriculitis	14
Plasma effects on bacterial time-kill dynamics: Insights from a PK/PD modelling analysis	14
Formation of a novel multiresistance plasmid co-carrying tigecycline, carbapenem, and other resistance genes by recombination during conjugative transfer in Klebsiella pneumoniae	14
Role of tcaA, a potential target as a ceftobiprole resistance breaker in MRSA β-lactam resistance	14
NucS Thr74Ile confers mutator phenotype in a globally disseminated clinical Mycobacterium abscessus subsp. abscessus clone	14
Head-to-head comparison of multi-dose oritavancin and dalbavancin for complicated infections: A propensity score-matched analysis	13
Clinical application of customized and non-customized bacteriophage therapy in patients with refractory/resistant bacterial infections: A systematic review and meta-analysis	13
Delivery of endolysin across outer membrane of Gram-negative bacteria using translocation domain of botulinum neurotoxin	13
Causality-informed models for multidrug-resistant organism prediction: Enabling effective ICU antibiotic stewardship	13
In vitro activity of ceftolozane/tazobactam against multidrug-resistant Pseudomonas aeruginosa from patients in Western Europe: SMART 2017-2020	13
Emergence of carbapenem-resistant XDR Salmonella enterica in paediatric patients in South China: A genomic perspective study	13
Unveiling the clonal dynamics and transmission mechanism of carbapenem-resistant Klebsiella pneumoniae in the ICU environment	13
Title Page & Editorial Board	13
Enhancing the identification of voriconazole-associated hepatotoxicity by targeted metabolomics	13
Resistance to aztreonam-avibactam among clinical isolates of Escherichia coli is primarily mediated by altered penicillin-binding protein 3 and impermeability	13
The evolution of carbapenem-resistant Pseudomonas aeruginosa in the COVID-19 era: A global perspective and regional insights	13
Investigating an outbreak of extensively drug-resistant Acinetobacter baumannii in a tertiary healthcare centre in lebanon using next-generation sequencing	13
The T6SS Effector Hcp of Hypervirulent Klebsiella pneumoniae Exacerbates Liver Abscess by Inducing Macrophage-HMGB1/RAGE-Dependent Endothelial Pyroptosis	13
Investigation of PhoP response regulator inhibition to overcome resistance in Gram-negative clinical bacteria	13
Phylogenetic insights of a human-derived optrA-positive Staphylococcus aureus isolated from a person with chronic diarrhea in China	13
IGRA-based INH regimen for prevention of active tuberculosis after kidney transplantation: A single-centre retrospective study	13
Genetic alterations in methicillin-susceptible Staphylococcus aureus associated with high vancomycin minimum inhibitory concentration	13
Epidemiology, treatment and outcomes of bloodstream infections due to MBL-producing Enterobacterales in France: A retrospective study	13
Activity of cefiderocol and innovative β-lactam/β-lactamase inhibitor combinations against isogenic strains of Escherichia coli expressing single and double β-lactamases under high and low permeabilit	13
Efficacy of a bacteriophage cocktail (Arash and Ariobarzanes) in the treatment of Salmonella typhimurium infection in a rat model	13
Exploration of the optimal GS-441524 trough concentration for treating COVID-19	12
Blockade of pan-viral propagation by inhibition of host cell PNPT1	12
Identification of a multi-replicon plasmid co-harboring mcr-1 and tmexCD3-toprJ1 in Escherichia coli ST101 isolated from wastewater in South Korea	12
In vitro activity of imipenem/relebactam against non-Morganellaceae Enterobacterales and Pseudomonas aeruginosa in the Asia-Pacific region: SMART 2017-2020	12
Indocyanine green clearance test as a predictor of linezolid overexposure in septic patients	12
Controlling biofilm and virulence properties of Gram-positive bacteria by targeting wall teichoic acid and lipoteichoic acid	12
Should the trough concentration of vancomycin be abandoned in therapeutic drug monitoring? A multicentre, retrospective study of critically ill patients without any form of dialysis	12
Effect of pre-hospitalization use of oral antiviral agents on reducing critical illness and mortality for patients with COVID-19 pneumonia	12
Population pharmacokinetics of nirmatrelvir in Chinese patients with COVID-19: Therapeutic drug monitoring and dosing regimen selection in clinical practice	12
Evaluation of deoxythymidine-based cationic amphiphiles as antimicrobial, antibiofilm, and anti-inflammatory agents	12
Effect of achieving bone sterilisation on bone architecture and bone marrow, in an experimental rabbit model of osteomyelitis caused by carbapenemase-producing Enterobacterales	12
Clonal outbreak of NDM-1-producing Enterobacter hormaechei belonging to high-risk international clone ST78 with the coexistence of tmexCD2-toprJ2 and mcr-9 in China	12
MtrAB two-component system is crucial for the intrinsic resistance and virulence of Mycobacterium abscessus	12
Efficacy and pharmacokinetics of a stepwise isolated phage cocktail against carbapenem-resistant Klebsiella pneumoniae in a murine pneumonia model	12
Intestinal colonisation with hypervirulent or third-generation cephalosporin-resistant Klebsiella pneumoniae strains upon hospital admission in a general ward in Taiwan	12
Voriconazole therapeutic drug monitoring and hepatotoxicity in critically ill patients: A nationwide multi-centre retrospective study	12
Small-molecule antiviral treatments for COVID-19: A systematic review and network meta-analysis	12
A randomised, double-blind, placebo-controlled, first-in-human phase I study to characterise the safety, pharmacokinetics and immunogenicity of 9MW1411 in healthy Chinese subjects	12
Emergence of a clinical carbapenem-resistant Escherichia coli co-harboring blandm-5 and mcr-1.1 on the same plasmid	12
Development of ceftazidime–avibactam resistance driven by conversion of blaKPC-2 to blaKPC-78 during treatment of ST463 carbapenem-resistant Pseudomonas aeruginosa infection	12
A novel method to evaluate ceftazidime/avibactam therapy in patients with carbapenemase-producing Enterobactericeae (CPE) bloodstream infections	12
penA profile of Neisseria gonorrhoeae in Guangdong, China: Novel penA alleles are related to decreased susceptibility to ceftriaxone or cefixime	11
Risk factor analysis for the occurrence of colistin-related nephrotoxicity: A retrospective observational cohort study	11
Off-label use versus formal recommendations of conventional and novel antibiotics for the treatment of infections caused by multidrug-resistant bacteria	11
Multiple mechanisms mediate aztreonam-avibactam resistance in Klebsiella pneumoniae: Driven by KPC-2 and OmpK36 mutations	11
Effects of different resistance mechanisms on bacterial response to meropenem, ciprofloxacin, and their combination described by next-generation mechanism-based modelling	11
3-Fucosyllactose-mediated modulation of immune response against virus infection	11
Meta-analysis on safety of standard vs. prolonged infusion of beta-lactams	11
Aggressive joint pharmacokinetic/pharmacodynamic target attainment of TDM-guided continuous infusion meropenem-vaborbactam monotherapy: A valuable strategy for maximizing the microbiological outcome o	11
Safety and tolerability of switching to bictegravir/emtricitabine/tenofovir alafenamide versus continuing dolutegravir/lamivudine in people living with HIV with neuropsychiatric comorbidities: Week 24	11
Reversible vancomycin susceptibility within emerging ST1421 Enterococcus faecium strains is associated with rearranged vanA-gene clusters and increased vanA plasmid copy number	11
Intravenous combined with aerosolised polymyxins vs intravenous polymyxins monotherapy for ventilator-associated pneumonia: A systematic review and meta-analysis	11
Clinical outcomes and safety of intravenous polymyxin B-based treatment in critically ill patients with carbapenem-resistant Acinetobacter baumannii nosocomial pneumonia	11
Candida albicans biofilms: antifungal resistance, immune evasion, and emerging therapeutic strategies	11
Spanish nationwide survey of Pseudomonas aeruginosa cefiderocol susceptibility and resistance mechanisms	11
Combined treatment of Japanese spotted fever with tetracycline and fluoroquinolone requires careful evaluation using robust outcomes both in terms of its advantages and disadvantages	11